Tarlac logs 11 new COVID-19 cases in a week | Inquirer News

Tarlac logs 11 new COVID-19 cases in a week

/ 02:19 PM June 07, 2022

The provincial capitol of Tarlac in Tarlac City

The provincial capitol of Tarlac in Tarlac City. (Photo by Jun A. Malig)

MABALACAT CITY, Pampanga––Eleven new COVID-19 cases were registered in Tarlac province from May 31 to June 6, data from the Central Luzon Center for Health Development (CLCHD) showed.

The regional agency’s epidemiology and surveillance unit said Tarlac has 35 active cases as of Monday, June 6.

ADVERTISEMENT

Data from the CHLHD also showed that Tarlac had 29,001 COVID-19 cases since the start of the pandemic in 2020. Of this figure, 28,363 had recovered while 603 had died.

FEATURED STORIES

Tarlac has a case fatality rate (CFR) of 2.08 percent.

CFR is the proportion of individuals who died from a particular disease among all those diagnosed with it.

Of the provinces and highly urbanized cities in Central Luzon, Aurora has the highest CFR at 5.24, followed by Zambales (4.02), Nueva Ecija (2.48), Pampanga (2.23), Tarlac (2.08), Olongapo City (2.05), Angeles City (1.61), Bulacan (1.26), and Bataan (1.25).

lzb

RELATED STORIES:

7 Tarlac towns now COVID-free 

Tarlac to hold nighttime COVID-19 vaccination for daytime workers

3 babies in Tarlac City contract coronavirus

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: CLCHD, COVID-19, Tarlac

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.